Novagenix plays an active role in the planning, execution, and reporting of phase I-III studies conducted to obtain bioavailability/bioequivalence and pharmacokinetic (PK)/pharmacodynamic (PD) data, which support the research and development efforts of the pharmaceutical industry.
o Preparation of Clinical Study Protocol in accordance with Turkish Republic Ministry of Health Turkish Medicines and Medical Devices Agency, EMA/FDA legislations ve ICH requirements
o Preparation of documents such as ICF (Inform Consent Form), CRF (Case Report Form).
o Finalizing related documents by communicating with the sponsor and clinical center
o Preparing the labels of products
o Following determination of the clinical trial schedule, delivery of blood tubes and serum/plasma/biological material tubes to the clinical center
o Submisson the necessary applications and notifications regarding the completion of the study
o Transferring of biological samples from clinical center to Novagenix
o Reporting of results following the bioanalytical process